McKesson Cash on Hand 2010-2024 | MCK
McKesson cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- McKesson cash on hand for the quarter ending September 30, 2024 was $2.509B, a 0.59% decline year-over-year.
- McKesson cash on hand for 2024 was $4.583B, a 2.03% decline from 2023.
- McKesson cash on hand for 2023 was $4.678B, a 32.45% increase from 2022.
- McKesson cash on hand for 2022 was $3.532B, a 43.74% decline from 2021.
McKesson Annual Cash on Hand
(Millions of US $) |
| 2024 |
$4,583 |
| 2023 |
$4,678 |
| 2022 |
$3,532 |
| 2021 |
$6,278 |
| 2020 |
$4,015 |
| 2019 |
$2,981 |
| 2018 |
$2,672 |
| 2017 |
$2,783 |
| 2016 |
$4,048 |
| 2015 |
$5,341 |
| 2014 |
$4,193 |
| 2013 |
$2,456 |
| 2012 |
$3,149 |
| 2011 |
$3,612 |
| 2010 |
$3,731 |
| 2009 |
$2,109 |
McKesson Quarterly Cash on Hand
(Millions of US $) |
| 2024-09-30 |
$2,509 |
| 2024-06-30 |
$2,302 |
| 2024-03-31 |
$4,583 |
| 2023-12-31 |
$1,982 |
| 2023-09-30 |
$2,524 |
| 2023-06-30 |
$2,636 |
| 2023-03-31 |
$4,678 |
| 2022-12-31 |
$2,774 |
| 2022-09-30 |
$2,916 |
| 2022-06-30 |
$2,233 |
| 2022-03-31 |
$3,532 |
| 2021-12-31 |
$2,754 |
| 2021-09-30 |
$2,151 |
| 2021-06-30 |
$2,423 |
| 2021-03-31 |
$6,278 |
| 2020-12-31 |
$3,577 |
| 2020-09-30 |
$3,091 |
| 2020-06-30 |
$2,613 |
| 2020-03-31 |
$4,015 |
| 2019-12-31 |
$2,065 |
| 2019-09-30 |
$1,356 |
| 2019-06-30 |
$1,947 |
| 2019-03-31 |
$2,981 |
| 2018-12-31 |
$1,849 |
| 2018-09-30 |
$2,118 |
| 2018-06-30 |
$2,199 |
| 2018-03-31 |
$2,672 |
| 2017-12-31 |
$2,619 |
| 2017-09-30 |
$2,563 |
| 2017-06-30 |
$2,339 |
| 2017-03-31 |
$2,783 |
| 2016-12-31 |
$2,434 |
| 2016-09-30 |
$5,464 |
| 2016-06-30 |
$4,659 |
| 2016-03-31 |
$4,048 |
| 2015-12-31 |
$3,406 |
| 2015-09-30 |
$5,359 |
| 2015-06-30 |
$5,635 |
| 2015-03-31 |
$5,341 |
| 2014-12-31 |
$4,587 |
| 2014-09-30 |
$3,804 |
| 2014-06-30 |
$4,105 |
| 2014-03-31 |
$4,193 |
| 2013-12-31 |
$2,431 |
| 2013-09-30 |
$2,960 |
| 2013-06-30 |
$2,905 |
| 2013-03-31 |
$2,456 |
| 2012-12-31 |
$2,726 |
| 2012-09-30 |
$2,831 |
| 2012-06-30 |
$2,013 |
| 2012-03-31 |
$3,149 |
| 2011-12-31 |
$4,191 |
| 2011-09-30 |
$3,943 |
| 2011-06-30 |
$3,116 |
| 2011-03-31 |
$3,612 |
| 2010-12-31 |
$3,213 |
| 2010-09-30 |
$3,050 |
| 2010-06-30 |
$3,265 |
| 2010-03-31 |
$3,731 |
| 2009-12-31 |
$3,428 |
| 2009-09-30 |
$3,215 |
| 2009-06-30 |
$2,644 |
| 2009-03-31 |
$2,109 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$73.526B |
$308.951B |
|
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
|
